BIOPHEN™ Antithrombin 2.5
Processing...

BIOPHEN™ Antithrombin 2.5

Code: A221102-CAN
Manufacturer’s Part Number: 221102
Product size: 2 x 2.5 mL
Clearance: CE / HCL

Price: $92.00

Qty

Product Description

In EU: This Product is CE Marked.

Health Canada Licensed.

BIOPHEN™ AT (Anti-Xa) is a chromogenic assay measuring Antithrombin (AT) activity via the anti-Factor Xa pathway. Principle: patient AT + heparin (R1) ? AT-heparin complex inhibits bovine FXa ? residual FXa measured with chromogenic substrate (R2). AT activity inversely proportional to residual FXa. For thrombophilia screening (AT deficiency is a high-risk inherited thrombophilia with 5-8x increased VTE risk), DIC monitoring, heparin resistance investigation, and liver function assessment. Calibrate with Plasma Calibrator (222101). Controls: Normal (223201) + Abnormal (223301). Also available: AT anti-IIa variant and latex immunoassay for antigen levels. FDA 510(k) cleared. CE-IVD.

Product Characteristics

  • Total Assay Time: < 3 min
  • Detection Threshold: ≤ 5%
  • Dynamic Range: 0 to 100%
  • Intra-Assay CV: < 3%
  • Inter-Assay CV: < 5%
  • No known drug interference in the assay.
  • No interference of Heparin Cofactor II, Îą2-macroglobulin or Îą1-Antitrypsin.
  • No interference for hemoglobin concentrations up to 5 mg/mL, for Bilirubin concentrations up to 0.1 mg/mL, and for plasma from hyperlipaemic patients.

Product Components

  • R1: 2 x 2.5 mL Bovine Factor Xa.
  • R2: 2 x 2.5 mL Chromogenic substrate, specific for Factor Xa (SXa-11).
  • R3: 2 x 5 mL of Tris-Heparin Buffer.
  • Video of Product Components
    (Video can be viewed with Flash Plugin)

Product Applications

Diagnosis of congenital or acquired Antithrombin deficiencies.

Measurement of ATIII activity in biological milieu or purified fractions.

Material Safety Data Sheet (MSDS)

Data Sheet/Technical Data

Certificate of Analysis (COA)

Other Documents